1)Suichi T, Misawa S, Beppu M, et al:Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey. Neurology 93:e975-e983,2019
2)Dispenzieri A:POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management. Am J Hematol 96:872-888,2021
3)Abe D, Nakaseko C, Takeuchi M, et al:Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome. Blood 112:836-839,2008
4)Kawajiri-Manako C, Mimura N, Fukuyo M, et al:Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome. Am J Hematol 93:1161-1168,2018
5)Nagao Y, Mimura N, Takeda J, et al:Genetic and transcriptional landscape of plasma cells in POEMS syndrome. Leukemia 33:1723-1735,2019
6)Isshiki Y, Oshima M, Mimura N, et al:Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis. JCI Insight 7:e151482,2022
7)桑原聡:Crow-Fukase症候群の病態と新規治療.100:2275-2281,2011
8)Suichi T, Misawa S, Sato Y, et al:Proposal of new clinical diagnostic criteria for POEMS syndrome. J Neurol Neurosurg Psychiatry 90:133-137,2019
9)Misawa S, Sato Y, Katayama K, et al:Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 15:1129-1137,2016
10)Kawajiri-Manako C, Sakaida E, Ohwada C, et al:Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan. Biol Blood Marrow Transplant 24:1180-1186,2018
11)Ohwada C, Sakaida E, Kawajiri-Manako C, et al:Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood 131:2173-2176,2018
12)Li J, Duan MH, Wang C, et al:Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome. Leukemia 31:1375-1381,2017